Cargando…
Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
Presently, surgery is the only treatment approach for gastric cancer and improving the prognosis of locally advanced gastric cancer is one of the key factors in promoting gastric cancer survival benefit. The MAGIC study was the first to demonstrate the efficacy of neoadjuvant chemotherapy (NAC) in E...
Autores principales: | Tong, Xie, Zhi, Peng, Lin, Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Gastric Cancer Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911622/ https://www.ncbi.nlm.nih.gov/pubmed/36750998 http://dx.doi.org/10.5230/jgc.2023.23.e12 |
Ejemplares similares
-
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020) -
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021) -
Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer
por: Zhou, Jichun, et al.
Publicado: (2016) -
Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Lin, Jian-Xian, et al.
Publicado: (2022) -
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
por: Li, Song, et al.
Publicado: (2023)